Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mechanisms of HBV immune evasion.
Kuipery A, Gehring AJ, Isogawa M. Kuipery A, et al. Among authors: isogawa m. Antiviral Res. 2020 Jul;179:104816. doi: 10.1016/j.antiviral.2020.104816. Epub 2020 May 7. Antiviral Res. 2020. PMID: 32387476 Review.
Host-virus interactions in hepatitis B virus infection.
Guidotti LG, Isogawa M, Chisari FV. Guidotti LG, et al. Among authors: isogawa m. Curr Opin Immunol. 2015 Oct;36:61-6. doi: 10.1016/j.coi.2015.06.016. Epub 2015 Jul 15. Curr Opin Immunol. 2015. PMID: 26186123 Free PMC article. Review.
Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance.
Whitacre DC, Peters CJ, Sureau C, Nio K, Li F, Su L, Jones JE, Isogawa M, Sallberg M, Frelin L, Peterson DL, Milich DR. Whitacre DC, et al. Among authors: isogawa m. Hum Vaccin Immunother. 2020;16(2):251-268. doi: 10.1080/21645515.2019.1689745. Epub 2019 Dec 6. Hum Vaccin Immunother. 2020. PMID: 31809638 Free PMC article.
7-Deaza-7-fluoro modification confers on 4'-cyano-nucleosides potent activity against entecavir/adefovir-resistant HBV variants and favorable safety.
Hayashi S, Higashi-Kuwata N, Das D, Tomaya K, Yamada K, Murakami S, Venzon DJ, Hattori SI, Isogawa M, Sarafianos SG, Mitsuya H, Tanaka Y. Hayashi S, et al. Among authors: isogawa m. Antiviral Res. 2020 Apr;176:104744. doi: 10.1016/j.antiviral.2020.104744. Epub 2020 Feb 18. Antiviral Res. 2020. PMID: 32084506 Free PMC article.
HBV-Specific CD8+ T-Cell Tolerance in the Liver.
Baudi I, Kawashima K, Isogawa M. Baudi I, et al. Among authors: isogawa m. Front Immunol. 2021 Aug 6;12:721975. doi: 10.3389/fimmu.2021.721975. eCollection 2021. Front Immunol. 2021. PMID: 34421926 Free PMC article. Review.
Validation of cross-genotype neutralization by hepatitis B virus-specific monoclonal antibodies by in vitro and in vivo infection.
Hamada-Tsutsumi S, Iio E, Watanabe T, Murakami S, Isogawa M, Iijima S, Inoue T, Matsunami K, Tajiri K, Ozawa T, Kishi H, Muraguchi A, Joh T, Tanaka Y. Hamada-Tsutsumi S, et al. Among authors: isogawa m. PLoS One. 2015 Feb 18;10(2):e0118062. doi: 10.1371/journal.pone.0118062. eCollection 2015. PLoS One. 2015. PMID: 25693196 Free PMC article.
[Immune responses to HBV infection].
Isogawa M, Tanaka Y. Isogawa M, et al. Nihon Rinsho. 2015 Dec;73 Suppl 9:397-401. Nihon Rinsho. 2015. PMID: 26845966 Japanese. No abstract available.
71 results